The booming business in biosimilars – Business Standard
The booming business in biosimilarsBusiness StandardThe current biosimilars portfolio of Dr Reddy's Laboratories constitutes of filgrastim, peg-filgrastim, rituximab and darbepeotin alfa, which have commercial presence in 13 emerging countries. “…
